Filing Details

Accession Number:
0001437749-21-008295
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-04-05 19:08:54
Reporting Period:
2021-03-31
Accepted Time:
2021-04-05 19:08:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
787253 Natural Alternatives International Inc NAII Medicinal Chemicals & Botanical Products (2833) 841007839
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1115556 A Mark Ledoux 1535 Faraday Avenue
Carlsbad CA 92008
Ceo/Chairman Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-03-31 898 $15.50 39,193 No 4 S Direct
Common Stock Disposition 2021-03-31 1,000 $15.50 524,000 No 4 S Indirect By LeDoux Family Limited Partnership
Common Stock Disposition 2021-04-01 1,602 $15.50 37,591 No 4 S Direct
Common Stock Disposition 2021-04-01 1,500 $15.50 522,500 No 4 S Indirect By LeDoux Family Limited Partnership
Common Stock Disposition 2021-04-05 2,500 $16.20 35,091 No 4 S Direct
Common Stock Disposition 2021-04-05 2,500 $16.20 520,000 No 4 S Indirect By LeDoux Family Limited Partnership
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Indirect By LeDoux Family Limited Partnership
No 4 S Direct
No 4 S Indirect By LeDoux Family Limited Partnership
No 4 S Direct
No 4 S Indirect By LeDoux Family Limited Partnership
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 176,500 Indirect By Self as Trustee for the LeDoux Family Trust U/D/T December 21, 1992
Common Stock 69,416 Indirect By IRA
Common Stock 7,200 Indirect By Self as Custodian for Marcelle Jeannette LeDoux
Common Stock 800 Indirect By Self as Custodian for Jean-Marc Emile LeDoux
Common Stock 6,000 Indirect By Self as Custodian for Aimee LeDoux
Footnotes
  1. This transaction represents a sale pursuant to a Programmed Plan of Transactions Under Rule 10b5-1(c) of the Securities Exchange Act included as an Exhibit to Form 8-K filed with the SEC on March 26, 2021.